Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1FED 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 17Rare Diseases 3Neoplasms 3Neoplasm Metastasis 3Leukemia 3Recurrence 2Lymphoma 2Lung Neoplasms 2Leukemia, Myeloid, Acute 2Leukemia, Lymphocytic, Chronic, B-Cell 2Genetic Diseases, Inborn 2Esophageal Squamous Cell Carcinoma 2Carcinoma, Squamous Cell 2Adenocarcinoma Of Esophagus 2Turcot syndrome 1Small Cell Lung Carcinoma 1Sezary Syndrome 1Respiratory Aspiration 1Radiation Pneumonitis 1Prostate Cancer Diagnosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Oropharyngeal Neoplasms 1Oligodendroglioma 1Non-Muscle Invasive Bladder Neoplasms 1Newly Diagnosed Oligometastatic Prostate Cancer 1Neuroma, Acoustic 1Neurologic Manifestations 1Neurofibromatosis 2 1Neurofibromatoses 1

Interventions

Collagenases 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × FED × Connective Tissue Diseases × Clear all
NCT00004409 2015-03-25

Phase II Randomized Study of Collagenase in Patients With Residual Type Dupuytren's Disease

FDA Office of Orphan Products Development

Phase 2 Completed
36 enrolled

Arthritis, Connective Tissue Diseases, Dupuytren Contracture, Rare Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡